These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22729986)

  • 41. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nature of speech disorders in Parkinson disease].
    Pawlukowska W; Honczarenko K; Gołąb-Janowska M
    Neurol Neurochir Pol; 2013; 47(3):263-70. PubMed ID: 23821424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson's Disease.
    Martel-Sauvageau V; Tjaden K
    J Commun Disord; 2017 Nov; 70():1-11. PubMed ID: 29032347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria.
    Caligiuri MP
    Brain Lang; 1989 Apr; 36(3):493-502. PubMed ID: 2706450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Speaking Rate on Variability of Second Formant Frequency Transitions in Dysarthria.
    van Brenk F; Lowit A; Tjaden K
    Folia Phoniatr Logop; 2024; 76(3):295-308. PubMed ID: 37769645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Articulatory Range of Movement in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
    Lee J; Bell M
    Am J Speech Lang Pathol; 2018 Aug; 27(3):996-1009. PubMed ID: 29800071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statistical models of F2 slope in relation to severity of dysarthria.
    Kim Y; Weismer G; Kent RD; Duffy JR
    Folia Phoniatr Logop; 2009; 61(6):329-35. PubMed ID: 19864914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of utterance rate and length on the spatiotemporal index in Parkinson's disease.
    Chu SY; Barlow SM; Lee J; Wang J
    Int J Speech Lang Pathol; 2020 Apr; 22(2):141-151. PubMed ID: 31213093
    [No Abstract]   [Full Text] [Related]  

  • 50. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
    Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
    Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polar-phase indices of perioral muscle reciprocity during syllable production in Parkinson's disease.
    Chu SY; Barlow SM; Lee J; Wang J
    Int J Speech Lang Pathol; 2017 Dec; 19(6):616-627. PubMed ID: 28425760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How Well Does Diadochokinetic Task Performance Predict Articulatory Imprecision? Differentiating Individuals with Parkinson's Disease from Control Subjects.
    Karlsson F; Hartelius L
    Folia Phoniatr Logop; 2019; 71(5-6):251-260. PubMed ID: 31117108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cepstral analysis of hypokinetic and ataxic voices: correlations with perceptual and other acoustic measures.
    Jannetts S; Lowit A
    J Voice; 2014 Nov; 28(6):673-80. PubMed ID: 24836365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Residual signal auto-correlation to evaluate speech in Parkinson's disease patients.
    Pereira JC; Schelp AO; Montagnoli AN; Gatto AR; Spadotto AA; de Carvalho LR
    Arq Neuropsiquiatr; 2006 Dec; 64(4):912-5. PubMed ID: 17220994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Language production in Parkinson's disease: acoustic and linguistic considerations.
    Illes J; Metter EJ; Hanson WR; Iritani S
    Brain Lang; 1988 Jan; 33(1):146-60. PubMed ID: 3342316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion rates.
    Rowe HP; Gochyyev P; Lammert AC; Lowit A; Spencer KA; Dickerson BC; Berry JD; Green JR
    J Neural Transm (Vienna); 2022 Dec; 129(12):1487-1511. PubMed ID: 36305960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurogenic Orofacial Weakness and Speech in Adults With Dysarthria.
    Solomon NP; Makashay MJ; Helou LB; Clark HM
    Am J Speech Lang Pathol; 2017 Aug; 26(3):951-960. PubMed ID: 28763804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.